Heterocyclic Anti-Inflammatory Agents E-Book
54,22 €
Mehr erfahren.
- Herausgeber: Bentham Science Publishers
- Kategorie: Wissenschaft und neue Technologien
- Sprache: Englisch
This book summarizes the cutting-edge experimental research on heterocyclic compounds used as anti-inflammatory agents in ten chapters. Each chapter is authored by experts in medicinal chemistry and is supplemented with scientific references for advanced reading.
The book covers several types of heterocyclic compounds and their derivatives including
· pyrimidine and pyrimidinone derivatives
· 1,2,3, and 1,2,4 triazoles
· imidazole and benzimidazole derivatives
· oxazole, oxadiazole, isoxazoline, and oxazoline derivatives
· thiazole and thiazolidinone derivatives
· pyrazole and pyrazoline
· carbazoles and their derivatives
· azipines, quinolines, and coumarins
This is a timely reference for medicinal chemists interested in developing new heterocycles for anti-inflammatory drugs. Contributors have discussed the effects of these compounds on different types of inflammation and their evolution in drug development as a therapeutic agent to give a wider perspective to readers.
Das E-Book können Sie in Legimi-Apps oder einer beliebigen App lesen, die das folgende Format unterstützen:
Seitenzahl: 258
Veröffentlichungsjahr: 2024
Ähnliche
BENTHAM SCIENCE PUBLISHERS LTD.
End User License Agreement (for non-institutional, personal use)
This is an agreement between you and Bentham Science Publishers Ltd. Please read this License Agreement carefully before using the ebook/echapter/ejournal (“Work”). Your use of the Work constitutes your agreement to the terms and conditions set forth in this License Agreement. If you do not agree to these terms and conditions then you should not use the Work.
Bentham Science Publishers agrees to grant you a non-exclusive, non-transferable limited license to use the Work subject to and in accordance with the following terms and conditions. This License Agreement is for non-library, personal use only. For a library / institutional / multi user license in respect of the Work, please contact: [email protected].
Usage Rules:
All rights reserved: The Work is the subject of copyright and Bentham Science Publishers either owns the Work (and the copyright in it) or is licensed to distribute the Work. You shall not copy, reproduce, modify, remove, delete, augment, add to, publish, transmit, sell, resell, create derivative works from, or in any way exploit the Work or make the Work available for others to do any of the same, in any form or by any means, in whole or in part, in each case without the prior written permission of Bentham Science Publishers, unless stated otherwise in this License Agreement.You may download a copy of the Work on one occasion to one personal computer (including tablet, laptop, desktop, or other such devices). You may make one back-up copy of the Work to avoid losing it.The unauthorised use or distribution of copyrighted or other proprietary content is illegal and could subject you to liability for substantial money damages. You will be liable for any damage resulting from your misuse of the Work or any violation of this License Agreement, including any infringement by you of copyrights or proprietary rights.Disclaimer:
Bentham Science Publishers does not guarantee that the information in the Work is error-free, or warrant that it will meet your requirements or that access to the Work will be uninterrupted or error-free. The Work is provided "as is" without warranty of any kind, either express or implied or statutory, including, without limitation, implied warranties of merchantability and fitness for a particular purpose. The entire risk as to the results and performance of the Work is assumed by you. No responsibility is assumed by Bentham Science Publishers, its staff, editors and/or authors for any injury and/or damage to persons or property as a matter of products liability, negligence or otherwise, or from any use or operation of any methods, products instruction, advertisements or ideas contained in the Work.
Limitation of Liability:
In no event will Bentham Science Publishers, its staff, editors and/or authors, be liable for any damages, including, without limitation, special, incidental and/or consequential damages and/or damages for lost data and/or profits arising out of (whether directly or indirectly) the use or inability to use the Work. The entire liability of Bentham Science Publishers shall be limited to the amount actually paid by you for the Work.
General:
Any dispute or claim arising out of or in connection with this License Agreement or the Work (including non-contractual disputes or claims) will be governed by and construed in accordance with the laws of Singapore. Each party agrees that the courts of the state of Singapore shall have exclusive jurisdiction to settle any dispute or claim arising out of or in connection with this License Agreement or the Work (including non-contractual disputes or claims).Your rights under this License Agreement will automatically terminate without notice and without the need for a court order if at any point you breach any terms of this License Agreement. In no event will any delay or failure by Bentham Science Publishers in enforcing your compliance with this License Agreement constitute a waiver of any of its rights.You acknowledge that you have read this License Agreement, and agree to be bound by its terms and conditions. To the extent that any other terms and conditions presented on any website of Bentham Science Publishers conflict with, or are inconsistent with, the terms and conditions set out in this License Agreement, you acknowledge that the terms and conditions set out in this License Agreement shall prevail.Bentham Science Publishers Pte. Ltd. 80 Robinson Road #02-00 Singapore 068898 Singapore Email: [email protected]
FOREWORD
It is my pleasure to write the foreword for the book entitled "Heterocyclic Anti-Inflammatory Agents: A Guide for Medicinal Chemists" edited by Anjaneyulu Bendi, M. P. Kaushik, and Neera Raghav. All the editors are well-known researchers working in different areas of organic and medicinal chemistry.
A large number of anti-inflammatory drugs are currently being used. However, many of these compounds are found to be highly unsafe for long-term use due to the associated toxicity. It has been established that the incorporation of heterocyclic moiety provides a useful tool for the modification of polarity, solubility, lipophilicity and hydrogen bonding capacity of such compounds. Going deeper into the book, the significance of heterocyclic compounds in the development of anti-inflammatory agents becomes apparent.
This book will be helpful for both, beginners and experimental researchers, working in the interdisciplinary areas involving chemistry, medicinal chemistry and pharmaceutical chemistry. It will also benefit the students who are pursuing a course involving the role of heterocyclic compounds in the development of medicinal agents in general, and of anti-inflammatory drugs in particular.
I hope that the book will be received well by the scientific community.
PREFACE
Are anti-inflammatory agents really requisite?
In ancient Egypt, Ebers Papyrus suggested rubbing a decoction of dried myrtle leaves on the back and abdomen to alleviate womb rheumatic pains about 3,500 years ago. A thousand years later, Hippocrates suggested to use the willow bark juice to reduce the fever and labour pains, and also recommended to use the poplar tree juice to treat eye problems. Celsus identified the four primary symptoms of inflammation (rubor, calor, dolor, and tumor, or redness, heat, pain, and swelling) in A.D. 30 and used willow leaf extract to treat them. This journey of utilizing extracts from different natural sources to reduce inflammation laid the foundation for aspirants in the modern era to develop novel drugs to treat different kinds of inflammation. Nowadays, different heterocyclic compounds have been used as anti-inflammatory agents.
This book highlights the cutting-edge experimental research on a variety of heterocycles used as anti-inflammatory agents in ten chapters. In Chapter 1, authors have briefly discussed the role of pyrimidine and pyrimidinone derivatives in the reduction of inflammation. Chapter 2 addresses the importance of 1,2,3- and 1,2,4- triazoles and their derivatives as anti-inflammatory agents. The chemistry of imidazole and benzimidazole derivatives to deal with the different kinds of inflammation has been discussed in Chapter 3.
Chapter 4 describes the synthesis of different oxazole, oxadiazole, isoxazoline, and oxazoline derivatives along with their biological evaluation as anti-inflammatory agents. A brief discussion of the chemistry of thiazole and thiazolidinone derivatives related to reducing inflammation has been described in Chapter 5.
In Chapter 6, authors have a special focus on exploring the chemistry of pyrazole and pyrazoline derivatives as anti-inflammatory agents. Chapter 7 deals with the importance of carbazoles and their derivatives in reducing different kinds of inflammation. The chemistry of azipines, quinolines, and coumarins has been discussed as anti-inflammatory agents in Chapter 8, Chapter 9 and Chapter 10.
In conclusion, we would like to say that the book's goal is to give an overview of the interesting research that is being done to design and make the new heterocycles as anti-inflammatory drugs. We hope that the content of this book will pique the interest of aspiring researchers everywhere and inspire them to continue their research in exploring novel heterocycles to treat different kinds of inflammation. We also hope that the book will be helpful to researchers, academics, and business people who have a strong interest in this research area.
We would like to express our admiration and gratitude for the efforts of all the authors who have worked enduringly on preparing the content of this book. We would also like to extend our heartfelt gratitude to the publishers and their employees for the efficient handling of the project at all stages. Lastly, we want to thank our family members for their unwavering support throughout the whole journey.
List of Contributors
Pyrimidine and Pyrimidinone Derivatives as Anti-Inflammatory Agents
Versha1,G.B. Dharma Rao2,Ravi Kumar Rana1,Anjaneyulu Bendi3,*Abstract
Heterocyclic compounds are one of the most significant sources of bio-active molecules. Pyrimidines and pyrimidinones are a class of nitrogen-containing heterocyclic compounds with significant biological activities. Among the different applications of these compounds in medicinal chemistry, their anti-inflammatory activities have attracted the attention of the scientific community to explore their chemistry. Some of these derivatives have been found to inhibit the production of pro-inflammatory cytokines and chemokine enzymes, which are involved in the recruitment and activation of immune cells at sites of inflammation. The chapter outlines the range of methods available to create different pyrimidine and pyrimidinone derivatives along with their anti-inflammatory activities.
INTRODUCTION
Heterocyclic compounds have gained significant attention due to their vast synthetic studies, functional utility, and multiple biological applications [1, 2]. These compounds are found in more than 90% of novel drugs and fill the gap between biology and chemistry, where so much scientific discovery and their applications occur. These are also prevalent in macromolecules like enzymes, vitamins, natural products, and are regarded as potential scaffolds in medicinal chemistry [3, 4].
Pyrimidine is a six-membered aza-aromatic compound that has profound biological applications in medicinal chemistry, which include anti-tumor, analgesic, anti-inflammatory, anti-fungal, anti-bacterial agents, etc [5]. Pyrimidines have been recently applied in coordination chemistry as electron-rich ligands that serve as interesting alternatives to pyridines [6]. The widespread applications are given a thought to further explore the chemistry of these compounds. Aside from the historical first syntheses by Brugnatelli and later by Kolbe [7], the Pinner synthesis had been the long-favored method for pyrimidines [8-10] (Fig. 1).
Fig. (1)) Synthetic strategies directed towards pyrimidines.The historical Pinner reaction is a condensation reaction between amidine and 1,3-dicarbonyl compounds that makes a variety of substituted pyrimidines. However, harsh reaction conditions and low yields have frequently hampered the pinner’s strategy. As a result, a wide range of strategies, ranging from cycloaddition reactions to multi-component and tandem processes, have been explored in order to broaden the scope and improve the yields of pyrimidines Scheme (1).
Scheme (1)) Classical pinner synthesis.The biosynthetic pathway of the pyrimidines was also observed along with their synthesis in laboratory conditions. The de-novo synthetic pathway is commonly used for the bio-synthesis of pyrimidines [11, 12]. The following steps are involved in their biosynthesis:
Step 1: Synthesis of carbamoyl phosphate from bicarbonate ion and the amide nitrogen of glutamine.
Step 2: Condensation of carbamoyl phosphate with aspartate to form carbamoyl aspartate.
Step 3: Ring closure to form dihydroorotate.
Step 4: Dihydroorotate is irreversibly oxidized to orotate by dihydroorotate dehydrogenase.
Step 5: Orotate reacts with 5-phospho-alpha-d-ribosyl-1-pyrophosphate to yield orotidine-5-monophosphate.
Step 6: the final reaction of the pathway is decarboxylation of OMP by OMP decarboxylase.
Along with the pyrimidines, pyrimidinones moieties also play a vital role in drug discovery. One of the most popular reactions is Biginelli reaction, which is a multi-component reaction that creates 3,4-dihydroprimidin-2-ones (DHPMs) by reacting aryl aldehyde, β-keto ester and urea under acidic conditions Scheme (2) [13-19].
Scheme (2)) Classical biginelli reactionInflammation is part of the body’s defence mechanism, and it is a process by which the immune system recognizes and removes harmful and foreign stimuli and begins the healing process. Pyrimidine and pyrimidinone derivatives have emerged as promising anti-inflammatory agents, with the ability to selectively target the underlying molecular mechanisms of inflammation.
CHEMISTRY OF PYRIMIDINE DERIVATIVES AS ANTI-INFLAMMATORY AGENTS
Mahmoud S. Tolba et al. introduced a new method for the synthesis of pyrimidine derivatives by carrying out the reaction of 2-(4-oxo-9-phenyl-7-(p-tolylamino)- 3,4-dihydropyrim-ido[4’,5’:4,5]thieno[2,3-d] pyrimidine-2-yl)acetohydrazide (1) with different reagents.
The synthesized compounds were tested for their ability to reduce inflammation by using Acute carrageenan-induced paw edema in rats. The results revealed that compounds (4) (57% and 62%), (7) (55% and 59%), (8) (57% and 61%), (9) (54% and 63%), and (10) (59% and 61%) were the most effective, while compounds (3) (53% and 60%), (5) (55% and 59%), (6) (54% and 60%), and (11) (52% and 60%) showed varying results at the second and fourth hours that were ranged from good to medium. Scheme (3) [20].
Priyanka T. Patil et al. investigated various novel pyrimidine derivatives as anti-inflammatory agents. The derivatives were synthesized by reacting aromatic aldehyde (12), 3-methyl-1-phenyl-2-pyrazoline-5-one (13) and 2-amino pyrimidine (14) using an efficient one-pot synthesis.
Scheme (3)) Synthesis of pyrimidine derivatives.The carrageenan rat paw edema model was used for studying the anti-inflammatory properties by comparing it with diclofenac Na (93%) standard drug. The compound (15c) showed the most potent activity with an inhibition of 86%. It has been found that aldehydes that have chloro groups at the second and fourth position, a nitro group at the second position showed good results. Scheme (4) [21].
Scheme (4)) Synthetic approach for novel pyrimidine derivatives.D. Giles et al. outlined the synthesis of pyrimidine derivatives (17a-I) by showing the cyclization reaction of chalcone derivatives indane-1,3-dione (16a-l) with urea.
The carrageenan-induced rat paw edema method was used to test all produced compounds for their anti-inflammatory properties. For 17e, a steady rise in paw edema inhibition was seen. Chlorophenyl substituted pyrimidine derivatives display good anti-inflammatory properties. They primarily bind to pro218 of 1CXZ and are compared to other derivatives. The ligand may have produced significant conformational changes in the protein structure. Scheme (5) [22].
Scheme (5)) Synthesis of pyrimidine derivatives of indane-1,3-dione.Mosaad S. Mohamed et al. used hydrazine hydrate (19a-d) with formic acid, carbon disulfide, acetic anhydride, or ethyl chloroformate to develop pyrrolo [2,3-d]pyrimidine derivatives (20-23). Benzaldehydes (19a-d) were refluxed in 100% ethanol to produce pyrrolopyrimidine derivatives (24a-d). By mixing sodium nitrite in acetic acid, compounds 19a and 19b were cyclized to produce derivatives 25a and 25b. Refluxing (19b-d) with acetylacetone produced (26b-d). After refluxing compounds 19a and 19b with chloroacetyl chloride, 27a and 27b were finally created.
The anti-inflammatory properties of each produced substance were examined. Compounds 19b, 24b, 24d and 26b generated a strong anti-inflammatory response at both the 3 and 4-h interval post-carrageenan, comparable to that of ibuprofen, compound 26b showed the most potent activity with an inhibition of 63.24 and 74.6% respectively at 3 and 4h interval post-carrageenan Scheme (6) [23].
Scheme (6)) Synthesis of anti-inflammatory active pyrrolo[2,3-d]pyrimidine derivatives.Ashish P. Keche et al. proposed a method for the synthesis of pyrimidine derivatives containing moieties of aryl urea, thiourea and sulfonamide. First of all, they synthesize the key intermediate 4-chloro-6-(4-nitrophenyl) pyrimidine (29) by carrying out the Suzuki cross-coupling between 4,4,5,5-tetramethyl-2-(4-nitrophenyl)-1,3,2-dioxaborolane (28) and 2,4-dichloropyrimidine followed by acid amination, reduction to yield desired amino analog (31) Then in the last step amine reacts with different arylisocyantes or arylisothiocynates or arylsulfonyl chlorides to form pyrimidine derivatives (32a-g), (33a-g) and (34a-g).
According to biological data, compounds 32a, 32b, 32g, 33a, 33b, 33e, and 34b out of all those examined were shown to exhibit moderate to powerful anti-inflammatory action (up to 48-78% TNF-alpha and 56-96% IL-6 inhibitory activity) in comparison to dexamethasone at 10µM. The anti-inflammatory activity can be attributed to the presence of urea or thiourea moiety in the pyrimidine scaffold Scheme (7) [24].
Scheme (7)) Synthesis of pyrimidine derivatives containing moieties of aryl urea, thiourea and sulphonamide.Mosaad S. Mohamed et al. reported the synthesis of thio-containing pyrrolo [2,3-d] pyrimidine derivatives. For the preparation of pyrrolo[2,3-d] pyrimidine-2 and/or 4 thione derivatives (40a-f) pyrroles (35a-c) were used as a starting material. Pyrrolo [2,3-d] pyrimidine (42) was produced via the alkylation of thione compounds in basic media. Additionally, some 2-amino pyrrole [2, 3-d] pyrimidines (43) were obtained.
By using the carrageenan-induced rat paw oedema assay, the anti-inflammatory activity of these synthesized compounds in vivo was evaluated. In vivo, compounds (40b) and (43a) are more effective at reducing inflammation than ibuprofen. With inhibition of 95% (2h and 3h post-carrageenan) and 79% (4h post-carrageenan), respectively. Additionally, in-vivo anti-inflammatory activity was rapidly observed (2h and 3h) and sustained after 4h, whereas ibuprofen activity decreased quickly. Compounds (40c), (40h), and (43b) displayed a stronger inhibitory activity at 2h and 3h for carrageenan-induced oedema than ibuprofen Scheme (8) [25].
Scheme (8)) Synthesis of thio-containing pyrrolo [2,3-d] pyrimidine derivatives.Sham M. Sondhi noted the synthesis of monocyclic pyrimidine derivatives (44), (45) and (46) Scheme (9) by showing the condensation of 3-Aminobenzonitrile and 2-amino-4-phenyl thiazole with 4-isothiocyanato-4-methyl pentane-2-one. 3-aminopropyl imidazole condensed into a monocyclic pyrimidine derivative (47) when it was combined with 3-isothiocyanato butanal. In order to create the bicyclic pyrimidine derivatives (48a) and (48b), diaminomaleonitrile was condensed with 4-isothiocyanto-4-methylpentane-2-one and 3-isothiocyanato butanal, respectively. (Scheme 10) [26]. The carrageenin-induced paw oedema assay was used to screen the anti-inflammatory activity, and compounds (44), (46), and (48b) showed good anti-inflammatory action, measuring 27.9, 34.5, and 34.3% at 50 mg/kg po, respectively.
Scheme (9)) Synthesis of monocyclic pyrimidine derivatives by condensation. Scheme (10)) Synthesis of bicyclic pyrimidine derivatives by condensation.CHEMISTRY OF PYRIMIDINONES AS ANTI-INFLAMMATORY AGENTS
Mona F. Said noted the synthesis of various pyrimidinones derivatives (51a-i) by first reacting (49a-c) with 2-acetylbutyrolactone in the presence of POCl3 to synthesize (50a-c). The synthesized compound (50a-c) was further reacted with different secondary amines to obtain the desired compounds (51a-i).
The products were evaluated for their anti-inflammatory activity by using carrageenan-induced rat paw method and indomethacin was used as a reference standard. Among the synthesized components with potencies of 104% and 129%, piperidino derivative (51b) and phenyl piperazino derivative (51g) were discovered to be the most potent ones (Scheme 11) [27].
Scheme (11)) Synthetic of anti-inflammatory active pyrimidine derivatives.Gina N. Tageldin et al. described the synthesis of pyrazolo[3,4-d]pyrimidinone derivatives containing thiazolidinone moiety by reacting the hydrazinyl derivative (52) with bis(carboxymethyl)tricarbonate in boiling ethanol to give thioxo-thiazolidinyl derivative (53). Then (53) underwent knoevenagel condensation with different substituted aromatic aldehydes to synthesize (54a-e). The desired mannich bases (55a-c) were obtained by heating the (53) with paraformaldehyde and various secondary amines in ethanol. The intermediate (56) was made by combining the hydrazine derivative (52) with chloroacetyl chloride in DMF. By heating (56) with ammonium thiocyanate, the corresponding thiazolidinone (57) was generated. Knoevenagel condensation of the active methylene of compound (57) with aromatic aldehyde in dioxane synthesize (58a-d) (Scheme 12).
Scheme (12)) Synthetic approach for thiazolidinone linked pyrimidinones.Compounds (53), (57) and (58d) with inhibition of 85.7%, 78.6% and 57.14%, respectively demonstrated anti-inflammatory action higher than both references in the formalin-induced paw edoema model, according to in vivo anti-inflammatory data. On the other hand, in the cotton pellet-induced granuloma assay, compounds (53), (54d), (54e), (58b) and (58d) showed anti-inflammatory action with inhibition of 45.6%, 40.3%, 33.2%, 39.5% and 38.2% respectively more than or almost equivalent to diclofenac sodium. In controlling both acute and chronic inflammation with a safe gastrointestinal margin, substances (53) and (58d) were regarded as viable options [28].
Jyoti M. Madar et al. synthesized a series of coumarin-linked pyridopyrimi dinones (63a-n). The synthesis was done in four steps. The first step was the synthesis of substituted 4-formyl coumarin obtained by transformation of 4-bromomethuk coumarin (59) by reacting with DMSO in ethanol. In the second step Baylis Hillman adduct (61) is produced by the interaction of 4-formyl coumarin and activated alkene (methyl acrylate). The third step was the conversion of the adduct (61) into corresponding acetate (62). The final step was the synthesis of coumarin-linked pyrido [1,2-a]pyrimidin-2-ones from acetate (62).
Gelatin gemography was used to test all recently synthesised compounds (63a-n) for their in vitro anti-inflammatory action against members of the MMP family, such as MMP-2 and MMP-9. Compounds 63a and 63m containing methyl group are found to be highly effective against MMP-2 as they showed 90% inhibition and tetracycline exhibited 95% inhibition (Scheme 13) [29].
Scheme (13)) Coumarin-linked pyridopyrimidinones.Adnan A. Bekhit developed a protocol for the synthesis of novel pyrimidinone derivatives containing thieno and triazolothieno moiety by taking 3-Benzyl-2-sulfanyl-5,6,7,8-tetrahydrobenzo[b]thieno[2,3-d]pyrimidin-4(3H)-one (65) as the starting key compound prepared from the aminoester (64). Additionally, methyl ion was used to S-alkylate molecule (65) to create methylsulfanyl derivative (66). Moreover, by refluxing 2-methylsulfanyl derivative (66) with hydrazine hydrate to give 2-hydrazino derivative (67). Then, compound (68) was synthesized by the reaction of the 2-hydrazino derivative (67) with ethyl chloroformate in dry piperidine. Moreover, triazolo derivative (69) or the 1-sulfanyl triazole By using chloroacetonitrile, alkyl or aralkyl halides, ethyl chloroacetate or phenacyl bromides, the sulfan-yl derivative (70) was alkylated to the corresponding sulfanyl acetonitrile derivative (71), S-alkyl or S-aryl derivatives (73a-c), ethoxy carbonyl methyl sulfanyl derivative (74) or aroylmet-hylsulfanyl derivatives (75a) and (75b).
All newly synthesized compounds were evaluated for anti-inflammatory activity by using the cotton-pellet granuloma bioassay in rats and indomethacin was used as a standard compound. Among the synthesized compounds, compounds 70 and 73a showed more effective anti-inflammatory effects than indomethacin. At the same dose and under the same test conditions, compound (68) was almost as powerful as indomethacin. Additionally, the anti-inflammatory effect of compounds (69), (73b), (73c), (74) and (75a) was mild (Scheme 14) [30].
Alaa A. El-Tombary proposed a method for the synthesis of pyrimidinones derivatives by taking 5-amino-6-methyl-1-phenyl-1,5-dihydro-4/-/-pyrazolo [3,4-ci]pyrimidin- 4-one (76) as the starting material. Condensation of (76) with benzaldehyde or p-chlorobenzaldehyde in glacial acetic acid results in 5-(arylideneamino)-6-methyl-1-phenyl-1,5-diyhdro-4H-pyrazolo- [3,4-d]pyrimidin- 4-one derivatives (78a,b). 5-(2- aryl-4-oxo-1,3-thiazolidin-3-yl) derivatives (80a,b) were obtained by cyclocondensation of Schiff's bases (78a,b) with thioglycolic acid in refluxing dry benzene. 5-(arylthiocarbamoyl)amino derivatives (81a,b) were synthesized by the reaction of (76) with 5- (arylthiocarbamoyl)amino derivatives. Then, 5-[(3-aryl-4-oxo-1,3-thiazolidin-2- ylidene)amino] derivatives (82a,b) or 5-[(3,4-diarylthiazol-2(3/-/)-ylidene)amino] derivatives (83a-f) were synthesized by the cyclocondensation of the thiourea derivatives (81a,b) with ethyl bromoacetate, or the appropriate phenacyl bromide in refluxing absolute ethanol, in the presence of anhydrous sodium acetate.
Scheme (14)) Synthesis of novel pyrimidinone derivatives containing thieno and triazolothieno moiety.The synthesized compounds were screened for their anti-inflammatory activity by using the carrageenan-induced paw edema test in rats by taking indomethacin as the standard drug. The pyrazolo pyrimidine derivatives with thiazolidinone (82a,b) and thiazoline (83a-f) moieties showed good anti-inflammatory action (52.23-66.88% edema reduction), whereas the other investigated compounds showed moderate activity (28.03-47.77% edema reduction) (Scheme 15) [31].
Scheme (15)) Synthesis of anti-inflammatory active pyrimidinone derivatives.Pathak Devender and Sharma Neha synthesized various chalcones linked pyrimidinone hybrids as anti-inflammatory agents by first reacting the substituted benzaldehyde (85) with substituted acetophenone (84) in the presence of ethanolic sodium hydroxide solution, which resulted in substituted chalcone (86a-o). The synthesized compounds (86a-o) were further reacted with urea in an alkaline medium to form the desired 4,6 disubstituted pyrimidine-2-one derivatives (87a-o).
The findings of the biological screening showed that compounds (87a), (87b), (87c), (87f), (87g), (87j), (87k) and (87n) have considerable anti-inflammatory action. Among the products, compound (87j) was found to be the most effective compound having o-chloro group at one phenyl ring and p-amino group at another phenyl ring with ED50 12.20mg/Kg (Scheme 16) [32].
Scheme (16)) Synthesis of various chalcones linked pyrimidinone hybrids as anti-inflammatory agents.M. Ajitha and K. Rajnarayana reported the synthesis of pyrimidinone derivatives 92(A1-45) by using semicarbazone (91), which was synthesized from isatin in alcohol with the addition of semicarbazide hydrochloride and sodium acetate. Further, by using multicomponent one pot condensation, desired compounds 92 (A1-45) were synthesized by refluxing (91) with ethyl acetoacetate and an aromatic aldehyde.
The synthesized compounds were tested for their anti-inflammatory activity. Compounds (92A16), (92A15), (92A14), (92A13) and (92A12) showed greater anti-inflammatory activity. Among these four compounds, compound 92A16 (R=R2=Br, R1=H, R3=Cl) was the most effective with percent inhibition of (26.20, 35.15, 39.77 and 38.22) at 1hr, 2hr, 3hr and 4hr (Scheme 17) [33].
Mosaad S. Mohamed investigated various novel pyrimidinone derivatives by carrying out the reaction of 6-amino-2-thioxo-1H-pyrimidin-4-one (93) with different reagents. Compounds (94a-c) were obtained by the reaction of (93) with primary amines and excess formalin in methanol in the presence of acetic acid. Further, compounds (96a-e) were synthesized by reacting (93) with aromatic aldehydes in methanol, having a few drops of hydrochloric acid. Moreover, compounds (96a,b) were synthesized from (93) on reaction with aromatic aldehyde in DMF containing few drops of AcOH.
Scheme (17)) Indole based pyrimidinone derivatives.In comparison to ibuprofen (the standard anti-inflammatory drug), the anti-inflammatory activity of synthesized compounds was studied. Compounds (95c) and (96b) show greater activity than ibuprofen and the greater activity of compounds (95c) and (96b) may be due to the presence of an indolyl group as a substituent (Scheme 18) [34].
Scheme (18)) Synthetic pathway of pyrimidinone derivatives.V. Alagarsamy et al. proposed a method for the synthesis of 3-Subsituted- amino-2-methyl-sulfanyl-5,6,7,8-tetrahydro-3H-benzo [4, 5]thieno[2,3-d]pyri-midin-4- ones by taking (113) as the intermediate compound which was prepared by treating carbon disulphide and sodium hydroxide solution simultaneously to a vigorously stirred solution of 2- amino-3-carbethoxy-4,5,6,7-tetrahydrobenzo [b]thiophene (110) in dimethyl sulphoxide. Compound (114) was obtained by dissolving (113) in a 2% alcoholic sodium hydroxide solution and methylating. The desired compounds (114a-j) were synthesized by condensation of (113) with different aldehydes and ketones.
A carrageenan-induced paw oedema protocol in rats was used to assess the anti-inflammatory activity. Comparing the anti-inflammatory activity of compounds (114a) and (114c) to that of the reference standard diclofenac sodium, the compounds (114a) and (114c)showed more potent anti-inflammatory activity, whereas compound (114b) demonstrated equal anti-inflammatory activity (Scheme 19) [35].
Scheme (19)) Synthesis of 3-Subsituted- amino-2-methylsulfanyl-5,6,7,8-tetrahydro-3H- benzo [4, 5]thieno[2,3-d]pyrimidin-4-ones.Hend N. Hafez et al. deduced a new series of pyrimidinones as anti-inflammatory agents.5-Aryl-8-arylmethylene-7,8-dihydro-2-thioxo-6H-cyclopenta [5, 6]pyrido [2, 3-d]-pyrimidin-4(H)-ones (98a-c) were obtained by the reaction of (97a-c) with hydrazine hydrate. Further compound (98c) synthesizes (100a,b) on heating with aliphatic acid. Moreover, compounds (101a,b) were synthesized by alkylation of (100a,b). Compounds (102a,b) were obtained when (98c) was heated with alpha-haloketones. Additionally, derivatives (103a-c) were obtained from (98c) on treatment with aldehyde. The latter compounds were mildly heated in a bromine-sodium acetate mixture to cyclize them, resulting in (100d-f). Further compound (98c) reacts with nitrous acid to yield (104) and the latter compound reacts with zinc dust and acetic acid to give (105).
Compound (98c) on heating with ethyl cyanoacetate, pentane-2,4-dione and/ir 3-chloropen-tane-2,4-dione synthesize the (106a-c). Compound (107) was obtained by condensing (98c)
